Uhi Toh

2PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 10, 2026
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.

|Jun 05, 2020
Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer.

Uhi Toh, Sayaka Sakurai, Shuko Saku

Pageof 1

Frequent Collaborators

1 joint publications

Shigeki Shichijo

1 joint publications

Akira Yamada

1 joint publications

Tsuguo Iwatani

1 joint publications

Norikazu Masuda